Antiemetic Prophylaxis with Fosaprepitant and 5-HT(3)-Receptor Antagonists in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation

BACKGROUND: High-dose myeloablative conditioning prior to autologous hematopoietic stem cell transplantation (autoHSCT) in pediatric patients is usually highly emetogenic. The antiemetic neurokinin-1 receptor antagonist fosaprepitant was safe and effective in children receiving highly emetogenic che...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Drug Des Devel Ther
Main Authors: Cabanillas Stanchi, Karin Melanie, Willier, Semjon, Vek, Julia, Schlegel, Patrick, Queudeville, Manon, Rieflin, Nora, Klaus, Veronika, Gansel, Melanie, Rupprecht, Joachim Vincent, Flaadt, Tim, Binder, Vera, Feuchtinger, Tobias, Lang, Peter, Handgretinger, Rupert, Döring, Michaela
Formato: Artigo
Idioma:Inglês
Publicado: Dove 2020
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7524181/
https://ncbi.nlm.nih.gov/pubmed/33061297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S260887
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares